Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for OKUR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 7.245M
March 31, 2026 14.34M
December 31, 2025 5.933M
September 30, 2025 6.407M
June 30, 2025 7.904M
March 31, 2025 9.234M
December 31, 2024 11.08M
September 30, 2024 3.627M
June 30, 2024 1.848M
March 31, 2024 3.397M
December 31, 2023 7.751M
September 30, 2023 15.44M
Date Value
June 30, 2023 15.51M
March 31, 2023 11.78M
December 31, 2022 8.212M
September 30, 2022 10.46M
June 30, 2022 9.451M
March 31, 2022 9.094M
December 31, 2021 6.813M
September 30, 2021 6.735M
June 30, 2021 3.753M
March 31, 2021 144.04M
December 31, 2020 97.34M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Ironwood Pharmaceuticals, Inc. 446.97M
Theriva Biologics, Inc. 22.67M
Nkarta, Inc. 89.91M
Unicycive Therapeutics, Inc. 18.76M
ACADIA Pharmaceuticals, Inc. 436.29M

Total Liabilities (Quarterly) Related Metrics